These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 10480128)

  • 41. Factors influencing the activity of Bacillus thuringiensis var. israelensis treatments.
    Becker N; Zgomba M; Ludwig M; Petric D; Rettich F
    J Am Mosq Control Assoc; 1992 Sep; 8(3):285-9. PubMed ID: 1357088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Field trial of two Bacillus thuringiensis var. israelensis formulations for control of Aedes species mosquitoes in Michigan woodlands.
    Wilmot TR; Allen DW; Harkanson BA
    J Am Mosq Control Assoc; 1993 Sep; 9(3):344-5. PubMed ID: 8245946
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Production & formulation of Bacillus thuringiensis var. israelensis & B. sphaericus 1593.
    Desai SY; Shethna YI
    Indian J Med Res; 1991 Sep; 93():318-23. PubMed ID: 1778620
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Field trials with Vectolex (Bacillus sphaericus) and Vectobac (Bacillus thuringiensis (H-14)) against Anopheles gambiae and Culex quinquefasciatus breeding in Zaire.
    Karch S; Manzambi ZA; Salaun JJ
    J Am Mosq Control Assoc; 1991 Jun; 7(2):176-9. PubMed ID: 1895075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microbial larvicides for the control of nuisance aquatic midges (Diptera: Chironomidae) inhabiting mesocosms and man-made lakes in California.
    Rodcharoen J; Mulla MS; Chaney JD
    J Am Mosq Control Assoc; 1991 Mar; 7(1):56-62. PubMed ID: 2045809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evolution of resistance toward Bacillus sphaericus or a mixture of B. sphaericus+Cyt1A from Bacillus thuringiensis, in the mosquito, Culex quinquefasciatus (Diptera: Culicidae).
    Wirth MC; Jiannino JA; Federici BA; Walton WE
    J Invertebr Pathol; 2005 Feb; 88(2):154-62. PubMed ID: 15766932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of Bacillus sphaericus to control breeding of malaria vectors.
    Ansari MA; Sharma VP; Mittal PK; Razdan RK; Batra CP
    Indian J Malariol; 1989 Mar; 26(1):25-31. PubMed ID: 2806687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Performance of ULV formulations (Pesguard 102/Vectobac 12AS) against three mosquito species.
    Yap HH; Chong AS; Adanan CR; Chong NL; Rohaizat B; Malik YA; Lim SY
    J Am Mosq Control Assoc; 1997 Dec; 13(4):384-8. PubMed ID: 9474567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of Bacillus sphaericus formulations against the vector of bancroftian filariasis.
    Arunachalalm N; Reddy CM; Hoti SL; Kuppusamy M; Balaraman K
    Southeast Asian J Trop Med Public Health; 1991 Jun; 22(2):160-4. PubMed ID: 1948272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cross-resistance to Bacillus sphaericus strains in Culex quinquefasciatus.
    Rodcharoen J; Mulla MS
    J Am Mosq Control Assoc; 1996 Jun; 12(2 Pt 1):247-50. PubMed ID: 8827600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Operational studies with Valent VectoLex WDG, Bacillus sphaericus, in three Florida Mosquito Control Districts.
    Floore T; Rolen K; Medrano G; Jones F
    J Am Mosq Control Assoc; 2002 Dec; 18(4):344-7. PubMed ID: 12542192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of Bacillus thuringiensis var. israelensis on oviposition of Aedes albopictus (Skuse).
    Stoops CA
    J Vector Ecol; 2005 Jun; 30(1):41-4. PubMed ID: 16007954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of flowable concentrate formulations of Bacillus thuringiensis var. israelensis against black flies (Diptera:Simuliidae).
    Lacey LA; Heitzman CM
    J Am Mosq Control Assoc; 1985 Dec; 1(4):493-7. PubMed ID: 3880264
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relative potency of Bacillus thuringiensis var. israelensis and Bacillus sphaericus 2362 for Mansonia titillans and Mansonia dyari.
    Lord JC; Fukuda T
    J Am Mosq Control Assoc; 1990 Jun; 6(2):325-7. PubMed ID: 1973452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Larvicidal persistence of formulations of Bacillus thuringiensis var. israelensis to control larval Aedes aegypti.
    Vilarinhos PT; Monnerat R
    J Am Mosq Control Assoc; 2004 Sep; 20(3):311-4. PubMed ID: 15532933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aerially applied, liquid Bacillus thuringiensis var. Israelensis (H-14) for control of spring Aedes mosquitoes in Michigan.
    Knepper RG; Wagner SA; Walker ED
    J Am Mosq Control Assoc; 1991 Jun; 7(2):307-9. PubMed ID: 1895091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microdroplet application of mosquitocidal Bacillus thuringiensis using ultra-low-volume generator for the control of mosquitos.
    Seleena P; Lee HL; Nazni WA; Rohani A; Kadri MS
    Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):628-32. PubMed ID: 9185282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a self floating slow release formulation of Bacillus thuringiensis var. israelensis and its larvicidal activity.
    Prabakaran G; Padmanabhan V; Balaraman K
    Indian J Exp Biol; 2001 Jan; 39(1):82-4. PubMed ID: 11349533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toxicity of VectoLex (Bacillus sphaericus) products to selected Australian mosquito and nontarget species.
    Brown ID; Watson TM; Carter J; Purdie DM; Kay BH
    J Econ Entomol; 2004 Feb; 97(1):51-8. PubMed ID: 14998127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Field trials with tank mixtures of Bacillus thuringiensis subsp. israelensis and Bacillus sphaericus formulations against Culex pipiens larvae in septic tanks in Antalya, Turkey.
    Cetin H; Dechant P; Yanikoglu A
    J Am Mosq Control Assoc; 2007 Jun; 23(2):161-5. PubMed ID: 17847848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.